Strychnine, a potent and selective antagonist at glycine receptors, was fou
nd to inhibit muscle (alpha(1)beta(1)gamma delta, alpha(1)beta(1)gamma, and
alpha(1)beta(1)delta) and neuronal (alpha(2)beta(2) and alpha(2)beta(4)) n
icotinic acetylcholine receptors (AcChoRs) expressed in Xenopus oocytes, St
rychnine alone (up to 500 mu M) did not elicit membrane currents in oocytes
expressing AcChoRs, but, when applied before, concomitantly, or during sup
erfusion of acetylcholine (AcCho), it rapidly and reversibly inhibited the
current elicited by AcCho (AcCho-current), Although in the three cases the
AcCho-current was reduced to the same level, its recovery was slower when t
he oocytes were preincubated with strychnine, The amount of AcCho-current i
nhibition depended on the receptor subtype, and the order of blocking poten
cy by strychnine was alpha(1)beta(1)gamma delta > alpha(2)beta(4) > alpha(2
)beta(2). With the three forms of drug application, the Hill coefficient wa
s close to one, suggesting a single site for the receptor interaction,vith
strychnine, and this interaction appears to be noncompetitive. The inhibito
ry effects on muscle AcChoRs were voltage-independent, and the apparent dis
sociation constant for Ac-Cho was not appreciably changed by strychnine, In
contrast, the inhibitory effects on neuronal AcChoRs were voltage-dependen
t, with an electrical distance of approximate to 0.35. We conclude that str
ychnine regulates reversibly and noncompetitively the embryonic type of mus
cle AcChoR and some forms of neuronal AcChoRs. In the former case, strychni
ne presumably inhibits allosterically the receptor by binding at an externa
l domain whereas, in the latter case, it blocks the open receptor-channel c
omplex.